阿利库单抗;阿莫罗布单抗; 阿利西尤单抗
Alirocumab
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$600.00
Member price
Product Availability
3-5days
Price
$1600.00
Member price
Product Availability
3-5days
Price
$2800.00
Member price
Product Availability
3-5days
Price
$13000.00
Member price
Product Availability
3-5days
Price
$20000.00
Member price
Quantity
- +
Product Overview
Product Name Alirocumab
CAS1245916-14-6
AppearanceA liquid
Storage condition Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles
Security information
Product details

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation. Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia.

Related literature
Related
Sorry, no related items
History
Revaprazan hydrochloride; Revaprazan HCl
XAV-939
Anti-CD30 (brentuximab vedotin biosimilar) mAb
Sivelestat Sodium Tetrahydrate | EI546 sodium tetrahydrate | LY544349 sodium tetrahydrate | ONO5046 sodium tetrahydrate
Alirocumab
Mu-conotoxin
(E)-4-Hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide (SLU-PP-332)
Rosuvastatin EP Impurity C(Calcium Salt)
PD 169316
Tanshinone I | Tanshinone A